Theravance Biopharma Ownership | Who Owns Theravance Biopharma?
Theravance Biopharma Ownership Summary
Theravance Biopharma is owned by 93.34% institutional investors, 5.93% insiders, and 0.72% retail investors. Madison avenue partners, lp is the largest institutional shareholder, holding 17.63% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.19% of its assets in Theravance Biopharma shares.
TBPH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Theravance Biopharma | 93.34% | 5.93% | 0.72% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Madison avenue partners, lp | 8.51M | 17.63% | $72.18M |
| Weiss asset management lp | 7.46M | 15.44% | $63.24M |
| Blackrock | 3.78M | 7.83% | $32.06M |
| Irenic capital management lp | 2.76M | 5.72% | $23.41M |
| Newtyn management | 2.12M | 4.40% | $18.02M |
| Vanguard group | 2.00M | 4.15% | $16.98M |
| Park west asset management | 1.70M | 3.52% | $14.42M |
| State street | 1.27M | 2.62% | $10.75M |
| Oasis management | 1.16M | 2.40% | $9.82M |
| Camber capital management lp | 1.00M | 2.07% | $8.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Madison avenue partners, lp | 8.51M | 9.12% | $72.18M |
| Newtyn management | 2.12M | 3.38% | $18.02M |
| Irenic capital management lp | 2.76M | 2.86% | $23.41M |
| Weiss asset management lp | 7.46M | 2.39% | $63.24M |
| Oasis management | 1.16M | 2.21% | $9.82M |
| Park west asset management | 1.70M | 1.06% | $14.42M |
| Camber capital management lp | 1.00M | 0.23% | $8.48M |
| Virtus etf advisers | 38.39K | 0.16% | $325.51K |
| Gsa capital partners llp | 204.09K | 0.12% | $1.73M |
| Sherbrooke park advisers | 52.52K | 0.08% | $445.35K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Madison avenue partners, lp | 8.51M | 9.12% | 1.50M |
| Park west asset management | 1.70M | 1.06% | 542.84K |
| Newtyn management | 2.12M | 3.38% | 480.77K |
| Jpmorgan chase | 259.26K | 0.00% | 228.40K |
| Gsa capital partners llp | 204.09K | 0.12% | 204.09K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baupost group llc/ma | - | - | -4.20M |
| Pictet asset management sa | 878.65K | 0.01% | -1.16M |
| Vanguard group | 2.00M | 0.00% | -683.67K |
| Blackrock | 3.78M | 0.00% | -428.18K |
| Bank of montreal /can/ | - | - | -160.14K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sherbrooke park advisers | 52.52K | 0.08% | 52.52K | $445.35K |
| Mirae asset global etfs | 43.27K | 0.00% | 43.27K | $366.90K |
| Alps advisors | 37.94K | 0.00% | 37.94K | $321.76K |
| Verition fund management | 34.34K | 0.00% | 34.34K | $291.17K |
| Two sigma advisers, lp | 33.90K | 0.00% | 33.90K | $287.47K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Lindbrook capital | -53.00 |
| Covestor | -62.00 |
| Riggs asset managment | -114.00 |
| Parallel advisors | -186.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 121 | -9.02% | 45,773,807 | -2.84% | 93 | 1.00% | 53 | -22.06% | 41 | -8.89% |
| Jun 30, 2024 | 132 | 9.09% | 47,111,010 | -1.79% | 97 | 0.99% | 68 | 28.30% | 44 | -4.35% |
| Mar 31, 2024 | 121 | 1.68% | 47,969,701 | -1.71% | 99 | 1.02% | 53 | 15.22% | 46 | -4.17% |
| Dec 31, 2023 | 119 | 3.48% | 48,802,581 | -4.01% | 98 | 1.05% | 46 | 4.55% | 48 | 17.07% |
| Sep 30, 2023 | 115 | -5.74% | 50,842,548 | -3.68% | 97 | 1.12% | 44 | 4.76% | 41 | -18.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.08M | 2.19% | 767.00 |
| Pictet Biopharmaceutical Mother | 1.00M | 2.05% | -21.29K |
| iShares Russell 2000 ETF | 948.99K | 1.94% | -2.13K |
| Vanguard Institutional Extnd Mkt Idx Tr | 564.55K | 1.15% | -3.08K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 375.78K | 0.77% | -7.60K |
| Fidelity Small Cap Index | 373.75K | 0.76% | -9.20K |
| CREF Stock R1 | 369.86K | 0.76% | -59.19K |
| iShares Russell 2000 Value ETF | 344.27K | 0.70% | - |
| iShares Biotechnology ETF | 317.74K | 0.65% | -1.90K |
| Delaware Healthcare I | 208.78K | 0.43% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 11, 2024 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | $36.00K |
| Jul 10, 2024 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | $36.00K |
| May 01, 2024 | Samaha Eli | - | Buy | $8.75M |
| May 01, 2024 | Samaha Eli | - | Buy | $4.37M |
| Feb 22, 2024 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | $10.92K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | 2 | - |
| 2024 Q1 | - | 1 |
| 2023 Q4 | - | 3 |
TBPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools